Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.
about
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patientsCoping with stress and the emergence of multidrug resistance in fungiSystematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipientsNasopharyngeal carcinoma mimicking Aspergillosis rhinosinusitis: an unusual case report and review of the literatureAntifungal prophylaxis in pediatric hematology/oncology: new choices & new data.Prevalence of invasive fungal disease in hematological patients at a tertiary university hospital in SingaporeSystematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.Mechanisms underlying the exquisite sensitivity of Candida albicans to combinatorial cationic and oxidative stress that enhances the potent fungicidal activity of phagocytes.Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.Canadian clinical practice guidelines for invasive candidiasis in adults.Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.Postinduction Supportive Care of Pediatric Acute Myelocytic Leukemia: Should Patients be Kept in the Hospital?Discrete choice experiment to evaluate factors that influence preferences for antibiotic prophylaxis in pediatric oncology.Attitudes toward infection prophylaxis in pediatric oncology: a qualitative approachEfficacy of itraconazole prophylaxis for autologous stem cell transplantation in children with high-risk solid tumors: a prospective double-blind randomized study.Febrile neutropenia in hematologic malignancies.Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Establishment and application of real-time quantitative PCR for diagnosing invasive aspergillosis via the blood in hematological patients: targeting a specific sequence of Aspergillus 28S-ITS2.The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosisEvidence-based guidelines for empirical therapy of neutropenic fever in Korea.Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience.Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysEfficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center.Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis.Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology GroupElectronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.Management of fungal infections following allogeneic stem cell transplantation.Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in KoreaClinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.Antifungal prophylaxis associated with decreased induction mortality rates and resources utilized in children with new-onset acute myeloid leukemia.Should prophylactic thrombolysis be routine in clinical practice? Evidence from an autopsy case of septicemia.Rhabdomyolysis Following Initiation of Posaconazole Use for Antifungal Prophylaxis in a Patient With Relapsed Acute Myeloid Leukemia: A Case Report.Neutrophil function after bone marrow and hematopoietic stem cell transplant.Antifungal prophylaxis and treatment in patients with hematological malignancies.
P2860
Q24186457-AC38206F-421E-4A7E-B840-AA271AE660A7Q27025256-8E1E1CC6-4721-4285-8AFD-DBEF02164806Q28083874-EFC5CAAB-CF06-41FD-9205-D2683E87C26EQ28085064-500EF587-E6F3-4344-8B6D-AD6E46A31E6BQ33559503-7D473EE6-2F9E-483E-A813-456AA0D4627BQ33830897-3B4693DB-E645-467B-882A-7FA437FB65EDQ33876645-60DE4604-5F95-402F-B05A-57DD4D613249Q34165499-3CAE6960-0D17-4295-8905-F27874C36165Q34218399-81553A40-5B2B-46BC-B150-F7751A56AB54Q34237335-112D8A82-65C9-4DCC-A7C6-D3D5953D435BQ34336386-69382EB1-BC62-4A1E-8ACA-43E1922CCCCFQ34346926-0F0FE069-D2D1-4E5E-AB7D-515F8FEAD475Q34452116-0D9922A8-CCF1-4411-B829-7594F239395EQ34462307-3F2B881A-EC01-47FF-89E8-41CED329FA2AQ34635418-AE7CCD45-E2E3-49CC-85B3-141305D50107Q34655730-663B6A2B-A2B0-4EBA-8AF9-E7C408D17936Q34667166-117BD1B5-4A2A-459E-9253-B4A06B0CDCF3Q34750807-FD2F2565-0B7B-4B6D-BBD7-7879A2CFBA0EQ34772679-67C4A9C0-FB81-4BA5-9727-128FA461C7B2Q35033597-0B384DE0-8127-4129-9F6F-8495398B4BD9Q35672258-BE0DAD25-E719-4C0F-A59A-24C2018ADBAEQ35944724-74273E3E-169D-429D-B957-D78C64D38847Q35949528-79AB4AD3-973F-47D7-BB77-C8DDEE118238Q36225173-FFDE592E-2D8F-4AF5-985F-19E37DA71044Q36406975-727AAA0D-D9FE-4A9C-ABF1-D43EC4A9CF83Q36543654-4FCE31DD-1F30-4137-AF13-4B19913DC82FQ36620870-3AFF3E66-3D6B-4813-BA63-BF2F6D6A26D7Q36814599-0DE8D5AF-122E-4424-8082-9F23ABFA0308Q36826800-9A079CC5-A08A-433A-9159-47FA56D3A5D3Q37026715-151FB1A8-13F6-44F9-ABFC-93B6770DD04BQ37122502-2E053334-2BE9-468B-ABFF-42B44F5DAEE8Q37202860-E395A236-82C2-4418-848C-AAEBAB83C476Q37344532-532D3296-3345-4AD1-AFF4-8C7F5F8033F9Q37473671-58142813-6483-4020-AC64-812AA0F3C0B3Q37480190-B0F1560E-A4E9-4A43-84FF-4300E652F786Q37528435-83A241C5-A381-4A88-B005-C197E264277FQ37540958-793AFA46-8344-44F8-9C26-D57990037F44Q37632299-11DACFC7-D25B-4328-B14D-D0A02E6E0693Q37720761-AD58FC45-806F-4707-B7F3-7690355ABDE9Q37727168-ADC5276D-8EC3-4FBE-A6C4-6EF379DF0234
P2860
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@ast
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@en
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@nl
type
label
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@ast
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@en
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@nl
prefLabel
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@ast
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@en
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@nl
P2093
P921
P356
P1476
Antifungal prophylaxis in canc ...... atic review and meta-analysis.
@en
P2093
Anat Gafter-Gvili
Elad Goldberg
Eyal Robenshtok
Miriam Weinberger
Moshe Yeshurun
P304
P356
10.1200/JCO.2007.12.3851
P407
P577
2007-10-01T00:00:00Z